department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Indomethacin · pharmadog

pharmadog
drugs
Indomethacin

drug

patient view →

indomethacin

Marketedupdated 2mo ago

by ACP Nimble Buyer Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Indomethacin

generic

indomethacin

indication

Acute and Sub-Acute Bursitis

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Patent cliff

source: FDA Orange Book

first barrier falls

Apr 23, 2030

~3.8 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

Apr 23, 2030formulationUS 87348473.8y
Apr 23, 2030formulationUS 87348473.8y
Apr 23, 2030formulationUS 89929823.8y
Apr 23, 2030formulationUS 89929823.8y
Apr 23, 2030method-of-use (U-55)US 90894713.8y
Apr 23, 2030method-of-use (U-55)US 90894713.8y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 4

drugindomethacin ER3 co-mentions · 3 sources
companyGlenmark Pharmaceuticals Ltd3 co-mentions · 1 sources
tagRecall3 co-mentions · 3 sources
company$USDWMADE IN USA INC.1 co-mentions · 1 sources

Trials studying indomethacin

phase1Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)completedn=16
phase2IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3terminatedn=10
phase4A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)completedn=180
phase2IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavitycompletedn=105
phase1A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participantswithdrawn
phase3Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitiscompletedn=192